In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lanthanum Dioxycarbonate Drug Master File in Korea (Lanthanum Dioxycarbonate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lanthanum Dioxycarbonate. The MFDS reviews the Lanthanum Dioxycarbonate KDMF as part of the drug registration process and uses the information provided in the Lanthanum Dioxycarbonate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lanthanum Dioxycarbonate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lanthanum Dioxycarbonate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lanthanum Dioxycarbonate suppliers with KDMF on PharmaCompass.